Are poly(ADP-ribosyl)ation by PARP-1 and deacetylation by Sir2 linked?

BioEssays

Volumn 25, Issue 8, 2003, Pages 808-814

  Zhang, Jie ^a  

^a GUILFORD PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; DNA; HISTONE; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; NUCLEAR PROTEIN; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROTEIN P53;

ADENOSINE DIPHOSPHATE RIBOSYLATION; CELL ENERGY; DEACETYLATION; DICTYOSTELIUM DISCOIDEUM; DNA DAMAGE; DOWN REGULATION; EUKARYOTE EVOLUTION; GENE; GENE EXPRESSION; GENE FUNCTION; GENE SILENCING; GENETIC LINKAGE; GENETIC STABILITY; GENOMICS; HUMAN; LONGEVITY; MAMMAL CELL; MOLECULAR EVOLUTION; NONHUMAN; PROTEIN DEPLETION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN INDUCTION; REVIEW; SACCHAROMYCES CEREVISIAE; SIR2 GENE; SISTER CHROMATID EXCHANGE;

ANIMALS; ENERGY METABOLISM; HUMANS; MODELS, BIOLOGICAL; NAD; NIACINAMIDE; POLY ADENOSINE DIPHOSPHATE RIBOSE; POLY(ADP-RIBOSE) POLYMERASES; SIRTUINS;

EUKARYOTA;

EID: 0041589716     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.10317     Document Type: Review

References (34)

1. +-dependent deacetylases. Trends Biochem Sci 2003;28:41-48.
2. Yoshida M, Horinouchi S, Beppu T. Tricostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function. Bioessays 1995;17:423-430.
3. Tanner KG, Landry J, Sternglanz R, Denu JM. Silent information regulator 2 family of NAD-dependent histone/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose. Proc Natl Acad Sci USA 2000;97:14030-14032.
4. Bitterman KJ, Anderson RM, Cohen HY, Latorre-Esteves M, Sinclair DA. Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast Sir2 and human SIRT1. J Biol Chem 2002;47:45099-45107.
5. Burkle A. Physiology and pathophysiology of poly(ADP-ribosyl)ation. Bioessays 2001;23:795-806.
6. +-dependent protein deacetylase activity in the Sir2 protein family. Proc Natl Acad Sci USA 2000;97:6658-6663.
7. Zhang J. Beneficial effect of GPI 6150 treatment in multiple animal models of diseases. In: Zhang J, editor. PARP as a therapeutic target. Boca Raton: CRC Press. 2002. p 239-256.
8. Imai S, Armstrong CM, Kaeberlein M, Guarante L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 2000;403:795-800.
9. Landry J, Sutton A, Tafrov ST, Heller RC, Stebbins J, Pillus L, Sternglanz R. The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases. Proc Natl Acad Sci USA 2000;97:5807-5811.
10. Shieh WM, Ame JC, Wilson MV, Wang ZQ, Koh DW, Jacobson MK, Jacobson EL. Poly(ADP-ribose) polymerase null mouse cells synthesize ADP-ribose polymers. J Biol Chem 1998;273:30069-30072.
11. Smith S. The world according to PARP. Trends Biochem Sci 2001;26:174-179.
12. de Murcia G, Menissier-de Murcia J, Schreiber V. Poly(ADP-ribose) polymerase: molecular biological aspects. BioEssays 1991;13:455-462.
13. Simbulan-Rosenthal CM, Rosenthal DS, Luo RB, Samara R, Jung M, Dritschilo A, Spoonde A, Smulson ME. Poly(ADP-ribosyl)ation of p53 in vitro and in vivo modulates binding to its DNA consensus sequence. Neoplasia 2001;3:179-188.
14. Mendoza-Alvarez H, Alvarez-Gonzalez R. Regulation of p53 sequence-specific DNA-binding by covalent poly(ADP-ribosyl)ation. J Biol Chem 2001;276:36425-36430.
15. Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK, Guarente L, Weinberg RA. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 2001;107:149-159.
16. Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A, Guarente L, Gu W. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 2001;107:137-148.
17. Wielckens K, Schmidt A, George E, Bredehorst R, Hilz H. DNA fragmentation and NAD depletion. Their relation to the turnover of endogenous mono(ADP-ribosyl) and poly(ADP-ribosyl) proteins. J Biol Chem 1983;257:12872-12877.
18. Berger NA. Poly(ADP-ribose) in the cellular response to DNA damage. Radiat Res 1985;101:4-15.
19. Park SD, Kim CG, Kim MG. Inhibitors of poly(ADP-ribose) polymerase enhance DNA strand breaks, excision repair, and sister chromatid exchanges induced by alkylating agents. Environ Mutagen 1983;5:515-525.
20. de Murcia JM, et al. Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. Proc Natl Acad Sci USA 1997;94:7303-7307.
21. Meyer R, Muller M, Beneke S, Kupper J-H, Burkle A. Negative regulation of alkylation-induced sister-chromatid exchange by poly(ADP-ribose) polymerase-1 activity. Int J Cancer 2000;88:351-355.
22. Gray DA, Durkacz BW, Shall S. Inhibitors of nuclear ADP-ribosyl transferase retard DNA repair after N-methyl-N-nitroso-urea. Further evidence for the involvement of (ADP-ribose)n in DNA repair. FEBS Lett 1981;131:173-177.
23. Simbulan-Rosenthal CM, Ly DH, Rosenthal DS, Konopka G, Luo R, Wang ZQ, Schultz PG, Smulson ME. Misregulation of gene expression in primary fibroblasts lacking poly(ADP-ribose) polymerase. Proc Natl Acad Sci USA 2000;97:11274-11279.
24. Grube K, Burke A. Poly(ADP-ribose) polymerase activity in mononuclear leukocytes of 13 mammalian species correlates with species-specific life span. Proc Natl Acad Sci USA 1992;89:11759-11763.
25. Gartenberg MR. The Sir proteins of Saccharomyces cerevisiae: mediators of transcriptional silencing and much more. Curr Opin Microbiol 2000;3:132-137.
26. Gottschling DE. Gene silencing: two faces of SIR2. Curr Biol 2000;10: R708-R711.
27. Frye RA. Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. Biochem Biophys Res Commun 1999;260:273-279.
28. Tanny JC, Moazed D. Coupling of histone deacetylation to NAD breakdown by the yeast silencing protein Sir2: Evidence for acetyl transfer from substrate to an NAD breakdown product. Proc Natl Acad Sci USA 2001;98:415-420.
29. Yamamoto H, Okamoto H. Protection by picolinamide, a novel inhibitor of poly (ADP-ribose) synthetase, against both streptozotocin-induced depression of proinsulin synthesis and reduction of NAD content in pancreatic islets. Biochem Biophys Res Commun 1980;95:474-481.
30. Hageman GJ, Stierum RH. Niacin, poly(ADP-ribose) polymerase-1 and genomic stability. Mut Res 2001;475:45-56.
31. Ungerstedt JS, Blomback M, Soderstrom T. Nicotinamide is a potent inhibitor of proinflammatory cytokines. Clin Exp Immunol 2003;131:48-52.
32. Lin SJ, Defossez PA, Guarente L. Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science 2000;289:2126-2128.
33. Tissenbaum HA, Guarente L. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 2001;410:227-230.
34. Perkins E, et al. Novel inhibitors of poly(ADP-ribose) polymerase/PARP1 and PARP2 identified using a cell-based screen in yeast. Cancer Res 2001;61:4175-4183.